Valeant (VRX) to Syndicate $500M of Incremental Term Loans

May 30, 2012 8:06 AM EDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced plans to syndicate $500 million of incremental term loans under its existing senior secured credit facilities to fund repayment of amounts outstanding under its existing $275 million revolving facility and for general corporate purposes, including acquisitions.

The incremental term loans will mature in 2019 and are expected to have terms that are similar to the Company's existing $600 million Term Loan B facility, with certain modifications. The incremental term loans are expected to close in June 2012, subject to market and other customary conditions.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News

Add Your Comment